# Lung Cancer (NSCLC) Non-small-cell lung cancer is a strong berberine setting because it combines metabolic vulnerability, frequent treatment resistance, and common mutation burdens in pathways berberine appears to affect. ### Why berberine is relevant here NSCLC often involves difficult biology around: * EGFR and related signalling * p53 disruption * acquired resistance * cancer stem-cell persistence * high oxidative-stress adaptation Berberine's mechanisms overlap with each of these. ### Main mechanisms in NSCLC #### p53-independent growth arrest One of the most useful findings is that berberine does **not** appear to rely on intact p53 to slow NSCLC growth. In models including p53-deficient cells, berberine still produced significant growth arrest. That matters because p53 disruption is common in lung cancer. #### Cancer stem-cell suppression Berberine has also been shown to reduce cancer stem-like features in NSCLC models. That is relevant because stem-like populations are linked to recurrence and persistent treatment resistance. #### Apoptosis signalling Reported work also supports apoptosis through the **miR-19a / tissue factor / MAPK** axis. #### Ferroptosis-related combination potential In NSCLC, berberine has also been studied alongside ferroptosis-inducing strategies. These models suggest downregulation of **SLC7A11**, **GPX4**, and **Nrf2**, with lower glutathione and greater ferroptotic pressure. ### Practical interpretation NSCLC is one of the clearer examples of berberine as a resistance-oriented metabolic adjunct under investigation. The strongest points are: * activity even in **p53-deficient** settings * stem-cell suppression interest * overlap with ferroptosis biology * mechanistic relevance to EGFR-driven and oxidative-stress-buffered disease The evidence remains preclinical, but it is coherent and clinically relevant enough to justify attention. ### References ### Lung Cancer (NSCLC) ⭐⭐⭐⭐ p53-independent arrest, in vivo xenograft confirmation: Katiyar SK, et al. (2009). p53 cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Molecular Carcinogenesis, 48(1):24–37.\ 🔗 ]\() Multi-target potential and cancer stem cell suppression — comprehensive review: Alqahtani MS, et al. (2022). Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent in Human Cancers. Frontiers in Pharmacology / PMC.\ 🔗 ]\() {% hint style="warning" %} This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use. {% endhint %} {% hint style="info" %} © 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text. {% endhint %} --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/lung-cancer-nsclc.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.